NCT01697306 2025-01-30The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder CancerA.O.U. Città della Salute e della ScienzaPhase 2 Completed120 enrolled